Connect with us

Trends

Global ENT & bronchoscopy devices market to reach USD 9.9 billion by 2029

The “Global ENT & bronchoscopy devices market size, share, & Covid-19 impact analysis 2023-2029 – MedSuite – Includes: ENT endoscopes, ENT powered instruments, and 9 more” report has been added to ResearchAndMarkets.com’s offering.

In 2022, the global market for ENT endoscopic and bronchoscopic devices was valued at $6.8 billion. It is expected to grow at a compound annual growth rate (CAGR) of 5.4% during the forecast period, reaching $9.9 billion.

The comprehensive report collection on the worldwide market for ENT endoscopic and bronchoscopic devices includes a wide range of products, such as ENT endoscopes, ENT powered instruments, ENT hand instruments, ENT surgical energy devices, balloon dilation devices, drug-eluting stents, bronchoscopes, bronchoscopic hand instruments, tracheobronchial stents, bronchoscopic biopsy devices, and foreign body removal devices.

Market data included

  • Unit Sales, Average Selling Prices, Market Size & Growth Trends
  • Procedure Numbers
  • Covid-19 Impact Analysis
  • Market Drivers & Limiters
  • Market Forecasts Until 2029, and Historical Data to 2019
  • Recent Mergers & Acquisitions
  • Company Profiles and Product Portfolios
  • Leading Competitors

Global ENT endoscopic device market insights
The ENT endoscope market is projected to continue to hold the largest market share in terms of value during the forecast period, mainly due to the increasing demand for single-use endoscopes. Among all the segments in the ENT endoscopic device market, the ENT endoscope market has the highest growth rate, and it is expected to maintain its position as the fastest-growing market by the end of the forecast period.

Global bronchoscopic device market insights
The bronchoscope segment accounted for the largest share of the overall bronchoscopic device market in 2022 and is projected to maintain its dominant position throughout the forecast period. This segment’s growth is primarily driven by the increasing sales of single-use and ultrasound bronchoscopes.

Global ENT device market share insights
The Global ENT device market was lead by Olympus and Karl Storz.

In 2022, Olympus emerged as the leading competitor in the ENT endoscopic and bronchoscopic device market. The company had a significant presence in both the ENT and bronchoscopy device markets. In the ENT endoscopic device market, Olympus held notable market shares in several segments, including ENT endoscopes, powered instruments, hand instruments, and surgical energy devices.

Market segmentation summary
Global endoscopic device markets:
ENT endoscope market – MedCore – Includes:

  • Subsegments of single-use ENT endoscopes, reusable laryngoscopes, reusable rhinoscopes/sinuscopes, and reusable otoscopes.

ENT powered instrument market – MedCore – Includes:

  • Total subsegments of capital equipment and disposable markets.

ENT hand instrument market – MedCore – Includes:

  • Sinus, laryngeal and otological hand instruments.

ENT surgical energy device market – MedCore – Includes:

  • Capital equipment and radiofrequency (RF) and ultrasonic probes.

Balloon dilation device market – MedCore – Includes:

  • Balloon sets, and it does not include the market’s extended set.

Drug-eluting stent market – MedCore – Includes:

  • Drug-eluting stents only and does not include the market’s extended set.

Bronchoscope market – MedCore – Includes:

  • Subsegments of rigid, flexible, ultrasound and single-use bronchoscopes.

Bronchoscopic hand instrument market – MedCore – Includes:

  • Focuses on bronchoscopic hand instruments only and does not include the market’s extended set.

Tracheobronchial stent market – MedCore – Includes:

  • Metal and silicone tracheobronchial stents.

Bronchoscopic biopsy device market – MedCore – Includes:

  • Segments of bronchial forceps and transbronchial needle aspiration (TBNA) needle devices.

Foreign body removal market – MedCore – Includes:

  • Disposable and reusable foreign body removal devices.

A selection of companies mentioned in this report includes

  • Acclarent
  • ERBE
  • MedRx
  • Advanced Monitors Corporation
  • Ethicon
  • Medtronic
  • Aesculap
  • Fujinon
  • Merit Medical
  • Ambu
  • Getinge
  • Micromed Medizintechnik
  • American Diagnostic Corporation
  • GlobalMed
  • Millennium Surgical
  • Anthony Products
  • Grace Medical
  • Nouvag AG
  • ASSI
  • Hayden Medical
  • Olympus
  • ATMOS MedizinTechnik
  • Heine
  • OmniGuide
  • Bausch & Lomb
  • Hobbs Medical
  • Otometrics
  • BD
  • Hood Laboratories
  • Pentax
  • Bien-Air
  • Instrumentarium
  • Richard Wolf
  • BOMImed
  • Integra LifeSciences
  • Riester
  • Boston Medical Products
  • Intersect ENT
  • Sklar Surgical Instruments
  • Boston Scientific
  • IntuBrite
  • Smith & Nephew
  • Bovie Medical
  • Inventis
  • Stryker
  • BR Surgical
  • Invotec
  • Sutter
  • Brasseler
  • JEDMED
  • Symmetry Surgical
  • Clarus Medical
  • Karl Storz
  • Teleflex
  • Cogentix Medical
  • KaWe
  • TeleMed Systems
  • ConMed
  • KLS Martin
  • Thoracent
  • Cook Medical
  • LYMOL Medical
  • US Endoscopy
  • DePuy Synthes
  • Machida
  • Verathon
  • Ecleris
  • Medi-Globe
  • Welch Allyn 

Research and Markets

Copyright © 2024 Medical Buyer

error: Content is protected !!